Follow Us
https://www.thebody.com/author/jill-cadman

Jill Cadman

Latest by Jill Cadman

Promo Image
Comunidad y Recursos de VIH

Cambios Menstruales y el VIH

Tabla de Contenidos

El VIH y los Problemas Menstruales ¿Cómo Provoca Problemas el VIH? ¿Qué Más Puede Provocar Problemas Menstruales? ¿Pueden los Medicamentos Anti-VIH Afectar al Ciclo Menstrual? Encontrar la Causa de los Problemas Menstrual...

Promo Image
Hepatitis C

Avoid Smoking and Drinking if You Have Hepatitis C

About four million people in the U.S. have the hepatitis C virus (HCV). HCV can cause an infection of the liver that is usually spread through blood contact with an infected person. Many HIV-positive people are also infected with HCV. If not treated,...

Promo Image

Post-Exposure Prophylaxis Talk

Post-exposure prophylaxis (PEP) is sometimes referred to as the "morning-after pill" for individuals with unanticipated sexual or injection drug related exposures to HIV. This is misleading, as PEP is not as simple as swallowing a single pill. It is,...

Promo Image
News

HIV Levels Differ in Men and Women

In 1996, the Centers for Disease Control (CDC) announced the first declines in AIDS deaths among men since the beginning of the epidemic. During the same time period, AIDS deaths among women increased by 3%. The situation improved in 1997 when women ...

Promo Image
News

Obstacles to Treatment Success

Until it is possible for individuals with HIV to safely stop taking antiretrovirals, those who have started treatment must continue for the foreseeable future. Many factors contribute to the success or failure of a long-term treatment regimen. Among ...

Promo Image
News

Set Back for Nerve Growth Factor

Neuropathy is characterized by burning, aching, numbness and tingling, most commonly in the legs and feet. It is a result of damage to nerve fibers and is caused by either HIV itself or the toxic effects of certain antiretroviral drugs (usually d4T, ...

Promo Image
News

Efavirenz Pregnancy Warning

The Division of AIDS Services (DAIDS) has issued a pregnancy safety alert to its trial sites regarding efavirenz (also known as DMP 266 and Sustiva) based on information provided by the drug's manufacturer, DuPont Merck. A study conducted by the comp...

Promo Image

Improved Ganciclovir Regimens

The current difficulties in enrolling CMV trials notwithstanding (see Treatment Issues, Sept. 1997), valuable new information on the disease is emerging, and investigations into new products and technologies are going forward. Reports from September'...

Promo Image

Early Treatment for HIV-Infected Infants

With increased screening of pregnant women, many fetuses are known to be at risk for HIV infection. Therefore, infants born to HIV-infected women can be checked within the first weeks of life by PCR or culture assays for the presence of infectious vi...